Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$264M Buy
2,465,011
+273,400
+12% +$30.1M 3.56% 4
2026
Q1
$230M Buy
2,191,611
+177,900
+9% +$20.9M 3.21% 7
2025
Q4
$251M Sell
2,013,711
-409,100
-17% -$48.7M 3.21% 6
2025
Q3
$290M Sell
2,422,811
-44,100
-2% -$4.66M 3.05% 6
2025
Q2
$226M Sell
2,466,911
-89,600
-4% -$8.17M 2.34% 13
2025
Q1
$225M Buy
2,556,511
+372,100
+17% +$36.6M 2.31% 14
2024
Q4
$202M Buy
2,184,411
+21,800
+1% +$2.1M 2.01% 17
2024
Q3
$201M Buy
2,162,611
+271,500
+14% +$22.8M 1.89% 23
2024
Q2
$142M Buy
1,891,111
+246,800
+15% +$19.7M 1.34% 34
2024
Q1
$142M Buy
+1,644,311
New +$126M 1.3% 35

Other funds holding CRH

Findlay Park Partners's CRH Position: Q2 2026 in Review

Findlay Park Partners increased its CRH (CRH) stake by 12% in Q2 2026, buying an estimated $30.1M and bringing the position to 2,465,011 shares worth $264M. The position accounts for 3.56% of the portfolio, ranked #4.

Findlay Park Partners first reported a position in CRH in Q1 2024 and has held it in 10 quarters since. The position peaked at $290M in Q3 2025. 1,025 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • Findlay Park Partners held 2,465,011 shares of CRH worth $264M as of Q2 2026.
  • Findlay Park Partners bought 273,400 CRH shares in Q2 2026, an estimated $30.1M.
  • CRH made up 3.56% of Findlay Park Partners's portfolio in Q2 2026, its #4 holding.
  • Findlay Park Partners first reported a position in CRH in Q1 2024 and has held it in 10 quarters since.
  • Findlay Park Partners's CRH position peaked at $290M in Q3 2025.
  • 1,025 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on Findlay Park Partners's 13F filing for Q2 2026, filed 12 Aug 2026.